Applied Genetic Technologies Corp.
(NASDAQ : AGTC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.97%73.511.0%$1662.26m
AMGNAmgen, Inc. -0.45%218.211.3%$912.64m
REGNRegeneron Pharmaceuticals, Inc. 0.12%512.962.6%$838.70m
BIIBBiogen, Inc. 1.29%321.051.5%$803.32m
VRTXVertex Pharmaceuticals, Inc. -1.22%246.611.9%$654.46m
ILMNIllumina, Inc. 2.36%287.623.5%$500.86m
MRNAModerna, Inc. -1.73%31.860.0%$490.05m
ALXNAlexion Pharmaceuticals, Inc. -2.36%96.232.0%$302.00m
AAgilent Technologies, Inc. 2.14%78.331.6%$228.79m
INCYIncyte Corp. -1.07%86.812.5%$215.18m
EXASEXACT Sciences Corp. 1.04%67.0621.0%$180.99m
SGENSeattle Genetics, Inc. 0.54%120.326.1%$157.23m
BMRNBioMarin Pharmaceutical, Inc. -0.06%79.554.3%$148.36m
IMMUImmunomedics, Inc. 6.57%19.6411.9%$133.04m
NVAXNovavax, Inc. -0.76%17.05114.7%$128.79m

Company Profile

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.